ReP USP - Resultado da busca

Artigo de periodico
Immunomodulatory and antitumor effects of type I interferons and their application in cancer therapy (2017)
Medrano, Ruan Felipe Vieira; Hunger, Aline; Mendonça, Samir Andrade; Barbuto, José Alexandre Marzagão ; Strauss, Bryan Eric
Fonte: Oncotarget. Unidade: ICB
Assuntos: IMUNOLOGIA, CÉLULAS MORTAS, CÉLULAS SANGUÍNEAS, INTERFERON TIPO I, ADJUVANTES IMUNOLÓGICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MEDRANO, Ruan Felipe Vieira et al. Immunomodulatory and antitumor effects of type I interferons and their application in cancer therapy. Oncotarget, v. 8, n. 41, p. 71249-71284, 2017Tradução . . Disponível em: https://doi.org/10.18632/oncotarget.1953. Acesso em: 15 maio 2024.
APA
Medrano, R. F. V., Hunger, A., Mendonça, S. A., Barbuto, J. A. M., & Strauss, B. E. (2017). Immunomodulatory and antitumor effects of type I interferons and their application in cancer therapy. Oncotarget, 8( 41), 71249-71284. doi:10.18632/oncotarget.1953
NLM
Medrano RFV, Hunger A, Mendonça SA, Barbuto JAM, Strauss BE. Immunomodulatory and antitumor effects of type I interferons and their application in cancer therapy [Internet]. Oncotarget. 2017 ; 8( 41): 71249-71284.[citado 2024 maio 15 ] Available from: https://doi.org/10.18632/oncotarget.1953
Vancouver
Medrano RFV, Hunger A, Mendonça SA, Barbuto JAM, Strauss BE. Immunomodulatory and antitumor effects of type I interferons and their application in cancer therapy [Internet]. Oncotarget. 2017 ; 8( 41): 71249-71284.[citado 2024 maio 15 ] Available from: https://doi.org/10.18632/oncotarget.1953
Artigo de periodico
Reestablishment of p53/Arf and interferon-β pathways mediated by a novel adenoviral vector potentiates antiviral response and immunogenic cell death (2017)
Hunger, Aline; Medrano, Ruan F. V.; Zanatta, Daniela B.; Valle, Paulo R. Del; Merkel, Christian A.; Salles, Thiago de Almeida; Ferrari, Daniel G.; Furuya, Tatiane K.; Bustos, Silvina O.; Saito, Renata de Freitas; Costanzi-Strauss, Eugenia ; Strauss, Bryan E.
Fonte: Cell Death Discovery. Unidade: ICB
Assunto: HISTOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
HUNGER, Aline et al. Reestablishment of p53/Arf and interferon-β pathways mediated by a novel adenoviral vector potentiates antiviral response and immunogenic cell death. Cell Death Discovery, v. 3, p. 17017, 2017Tradução . . Disponível em: https://doi.org/10.1038/cddiscovery.2017.17. Acesso em: 15 maio 2024.
APA
Hunger, A., Medrano, R. F. V., Zanatta, D. B., Valle, P. R. D., Merkel, C. A., Salles, T. de A., et al. (2017). Reestablishment of p53/Arf and interferon-β pathways mediated by a novel adenoviral vector potentiates antiviral response and immunogenic cell death. Cell Death Discovery, 3, 17017. doi:10.1038/cddiscovery.2017.17
NLM
Hunger A, Medrano RFV, Zanatta DB, Valle PRD, Merkel CA, Salles T de A, Ferrari DG, Furuya TK, Bustos SO, Saito R de F, Costanzi-Strauss E, Strauss BE. Reestablishment of p53/Arf and interferon-β pathways mediated by a novel adenoviral vector potentiates antiviral response and immunogenic cell death [Internet]. Cell Death Discovery. 2017 ; 3 17017.[citado 2024 maio 15 ] Available from: https://doi.org/10.1038/cddiscovery.2017.17
Vancouver
Hunger A, Medrano RFV, Zanatta DB, Valle PRD, Merkel CA, Salles T de A, Ferrari DG, Furuya TK, Bustos SO, Saito R de F, Costanzi-Strauss E, Strauss BE. Reestablishment of p53/Arf and interferon-β pathways mediated by a novel adenoviral vector potentiates antiviral response and immunogenic cell death [Internet]. Cell Death Discovery. 2017 ; 3 17017.[citado 2024 maio 15 ] Available from: https://doi.org/10.1038/cddiscovery.2017.17
Artigo de periodico
Induction of oxidants distinguishes susceptibility of prostate carcinoma cell lines to p53 gene transfer mediated by an improved adenoviral vector (2017)
Esaki, Tamura Rodrigo; Hunger, Aline; Fernandes, Denise C.; Laurindo, Francisco R.; Costanzi-Strauss, Eugenia ; Strauss, Bryan E.
Fonte: Human Gene Therapy. Unidade: ICB
Assunto: HISTOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ESAKI, Tamura Rodrigo et al. Induction of oxidants distinguishes susceptibility of prostate carcinoma cell lines to p53 gene transfer mediated by an improved adenoviral vector. Human Gene Therapy, v. 28, n. 8, p. 639-653, 2017Tradução . . Disponível em: https://doi.org/10.1089/hum.2016.139. Acesso em: 15 maio 2024.
APA
Esaki, T. R., Hunger, A., Fernandes, D. C., Laurindo, F. R., Costanzi-Strauss, E., & Strauss, B. E. (2017). Induction of oxidants distinguishes susceptibility of prostate carcinoma cell lines to p53 gene transfer mediated by an improved adenoviral vector. Human Gene Therapy, 28( 8), 639-653. doi:10.1089/hum.2016.139
NLM
Esaki TR, Hunger A, Fernandes DC, Laurindo FR, Costanzi-Strauss E, Strauss BE. Induction of oxidants distinguishes susceptibility of prostate carcinoma cell lines to p53 gene transfer mediated by an improved adenoviral vector [Internet]. Human Gene Therapy. 2017 ; 28( 8): 639-653.[citado 2024 maio 15 ] Available from: https://doi.org/10.1089/hum.2016.139
Vancouver
Esaki TR, Hunger A, Fernandes DC, Laurindo FR, Costanzi-Strauss E, Strauss BE. Induction of oxidants distinguishes susceptibility of prostate carcinoma cell lines to p53 gene transfer mediated by an improved adenoviral vector [Internet]. Human Gene Therapy. 2017 ; 28( 8): 639-653.[citado 2024 maio 15 ] Available from: https://doi.org/10.1089/hum.2016.139

Unidades USP

ReP

Filtros

Autores

Assuntos

Indexado em

Afiliação dos autores externos não normalizada